First author | Year | Treatment | n | Cheng’s type (n) | 5-year survival rate, % | Median survival time, months |
---|---|---|---|---|---|---|
Wu CC 29 | 2000 | Surgery | 112 | I-II (97) | 28.5 | - |
III (15) | 26.4 | - | ||||
Poon RT 32 | 2003 | Surgery | 20 | II-III | 13.3 | 6.0 |
Ikai I 31 | 2006 | Surgery | 78 | II (35) | 10.1 | 11.4 |
III (43) | 12.0 | 8.9 | ||||
Chen XP 28 | 2006 | Surgery | 438 | I-II (286) | 18.1 | 18.8 |
III (152) | 0 | 10.1 | ||||
Shi J 26 | 2010 | Surgery | 406 | I (139) | 25.1 (3-year) | 22 |
II (169) | 17.7 (3-year) | 15 | ||||
III (78) | 3.6 (3-year) | 10 | ||||
IV (20) | 0 (3-year) | 8 | ||||
II-IV (1021) | 18.3 | - | ||||
Peng ZW 50 | 2012 | Surgery | 201 | I (27) | 37.9 (3-year) | - |
II (68) | 17.2 (3-year) | - | ||||
III (83) | 3.6 (3-year) | - | ||||
IV (23) | 0 (3-year) | - | ||||
Liu PH 30 | 2014 | Surgery | 247 | I-II | 59 | 64 |
Kim KM 39 | 2009 | TACE | 149 | I-II (57) CP Class A | - | 10.2 |
CP Class B | - | 5.5 | ||||
III (92) CP Class A | - | 5.3 | ||||
CP Class B | - | 4.7 | ||||
Luo J 40 | 2011 | TACE | 84 | I/II (40) | - | 10.2 |
III (44) | - | 5.3 | ||||
Niu ZJ 27 | 2012 | TACE | 115 | I (12) | - | 12 |
II (52) | - | 8.3 | ||||
III (42) | - | 5 | ||||
IV (9) | - | 2.43 | ||||
Peng ZW 50 | 2012 | TACE | 402 | I (54) | 8.9 (3-year) | - |
II (136) | 6 (3-year) | - | ||||
III (166) | 4.2 (3-year) | - | ||||
IV(46) | 4.3 (3-year) | - | ||||
Liu L 42 | 2014 | TACE | 188 | I-II (98) CP Class A | - | 9.8 |
CP Class B | - | 5.6 | ||||
III (90) CP Class A | - | 4.3 | ||||
CP Class B | - | 3.4 | ||||
Liu PH 30 | 2014 | TACE | 181 | I-II (181) | 50 (3-year) | 32 |